News

Press Release
RepliCel Reignites its First-in-Japan Strategy
RepliCel Reignites its First-in-Japan StrategyNext-stage trials in Japan present market launch opportunities for RepliCel’s skin... ...
Press Release
RepliCel CEO Provides 2019 Shareholder Update
With a new strategic plan, RepliCel prioritizes focus on commercial revenueVANCOUVER, BC, CANADA – 5 March, 2019 –... ...
Events
2018 GCFF Shenzhen Investing in North American Innovation Conference
RepliCel is presenting November 29, 2018 to Chinese attendees looking to invest in North American... ...
Events
Collaboration Meetings with YOFOTO & Participation in the YOFOTO 2018 Global Business Seminar
RepliCel and YOFOTO management will conduct their inaugural joint steering committee meetings on December 4-6,... ...
Events
2019 EBD Biotech Showcase
RepliCel is excited to have been chosen to present at next year's EBD Biotech Showcase... ...
Press Release
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
Appointment of Dr. Goessens-Rueck strengthens management team and fulfils commitment to promote female leadership in... ...
Press Release
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
The National Sciences and Engineering Research Council of Canada has funded a University of Victoria... ...
Press Release
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada (Copy)
The National Sciences and Engineering Research Council of Canada has funded a University of Victoria... ...
As Seen In
Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner
Canada-based biotech company signs major deal with Chinese partner to advance groundbreaking technology in the... ...
Press Release
RepliCel Life Sciences Appoints New Chief Financial Officer
VANCOUVER, Oct. 17, 2018 /CNW/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2)... ...
Press Release
RepliCel CEO Provides Updated Outlook
Partnership and Investment Fuel Plans for Upcoming Advancements VANCOUVER, Oct. 15, 2018 /CNW/ - RepliCel... ...
Press Release
RepliCel Life Sciences Completes Financing with YOFOTO (China) Health
 YOFOTO (China) Health and RepliCel Life Sciences finalize investment and commence collaboration activity in Greater... ...
Press Release
RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete Investment
YOFOTO (China) Health and RepliCel Life Sciences now cleared to close investment transaction and commence... ...
As Seen In
Partnership Greenlighted for Canadian Biotech and Chinese Health Products Firm
RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB) and YOFOTO Health Industry Co. Ltd. received approval from... ...
As Seen In
Canadian Technology and Innovation: making strides in the global cell therapy landscape
Another cell therapy rising star, RepliCel Life Sciences, is harnessing the healing properties of hair... ...
As Seen In
9 Challenges Keeping Cell And Gene Therapy Executives Up At Night
Despite recent progress in regenerative medicine, cell and gene therapy executives are still pioneering many... ...
Press Release
RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China
Skin rejuvenation and tendon regeneration products to be commercialized in Greater China in partnership with... ...
As Seen In
Is the Age-Old Quest for a Baldness Cure Reaching Its End?
Click here to read the full article and interview as it appears in The New... ...
As Seen In
RepliCel's regenerative technology could take the "Polar Silk Road" to China
New opportunities are arising at every turn for the regenerative medicine community. READ ARTICLE ... ...
Press Release
RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO
A revised binding term sheet reflects improved terms and positions the parties for closing the... ...

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.